Quantum Surgical

Montpellier, France Founded: 2010 • Age: 16 yrs
Minimally invasive surgical robotics for tumor ablation therapies are provided.

About Quantum Surgical

Quantum Surgical is a Healthcare company based in Montpellier (France) founded in 2010 by Fernand Badano, Sophie Roca, Lucien Blondel, and Bertin Nahum. Minimally invasive surgical robotics for tumor ablation therapies are provided. Quantum Surgical has raised $98 million across 5 funding rounds from investors including Caisse D Epargne, European Investment Bank and Bpifrance. Quantum Surgical has completed 1 acquisition, including NeuWave. Its chief executive, as recorded, is Bertin Nahum. Its Indian entity Quantum Surgicals Private Limited reported revenue of ₹11.14 Cr. Quantum Surgical offers products and services including Epione Robotic Platform. Its focus areas include Life Sciences, Oncology, Medical Devices and Surgical Tools.

Company details

Quantum Surgical was founded in 2010 in Montpellier, France, and operates in the medtech sector focused on surgical robotics. The Epione robotic platform is offered to support percutaneous ablation therapy, targeting liver cancer and inoperable tumors in the abdomen and lungs. Difficult-to-reach tumors are treated at early stages without open surgery, enabling precise interventions by physicians in oncology applications.

Key Metrics
  • Indian entity revenue
    ₹11.14 Cr

    FY 2025 · -28% YoY

  • Indian entity net profit
    ₹76.6 Lakh

    FY 2025 · 7% margin

  • Indian entity EBITDA
    ₹1.04 Cr

    FY 2025 · 9% margin

  • Total Equity Funding
    $98M (USD)

    in 5 rounds

  • Latest Funding Round
    $32.52M (USD), Debt – Conventional

    Mar 2024

  • Investors
  • Investments & Acquisitions

Products & Services of Quantum Surgical

Quantum Surgical offers a comprehensive portfolio of products and services, including Epione Robotic Platform.

Epione Robotic Platform
Medical Robotics

Robotic system for planning and executing tumor ablation in cancer treatment.

Funding Insights of Quantum Surgical

Quantum Surgical has successfully raised a total of $98M across 5 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $32.52 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $98M
  • Total Rounds 5
  • Last Round Debt – Conventional — $32.52M
  • First Round $50M

    (Jun 2018)

  • Investors Count 4

All 5 funding rounds of Quantum Surgical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2024$32.52MDebt – Conventional––
Oct 2021$48MSeries C–Ally Bridge Group
Oct 2021$17.4MDebt – Venture––
Jan 2020$2.22MGrant––
Jun 2018$50MSeries A–Ally Bridge Group
–
Valuation history

4 investors in total: 4 institutional.

Investors in Quantum Surgical

Quantum Surgical has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Caisse D Epargne, European Investment Bank and Bpifrance.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Finance and advisory services for infrastructure projects are provided.
1958eib.orgLuxembourg, Luxembourg
Private equity and hedge fund investments in healthcare are managed.
ally-bridge.comHong Kong, China
Corporate consultancy, advisory, and funding services are provided to businesses.
2012bpifrance.comMaisons Alfort, France
Semi-cooperative banking group
1818caisse-epargne.frParis, France
Premium access

Investor details for Quantum Surgical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Quantum Surgicals Private Limited (Quantum Surgical)

Quantum Surgicals Private Limited is the primary company behind Quantum Surgical. The board of Quantum Surgicals Private Limited currently have 2 directors; the longest-serving is Sawan Rajendra Khokale, appointed in 2012.

DirectorDesignationAppointedTenureEntity
Sawan Rajendra Khokale
DIN 05264857
Director16 May 201214 yrs 6 moQuantum Surgicals Private Limited
Sachin Rajendra Khokale
DIN 05264863
Director16 May 201214 yrs 6 moQuantum Surgicals Private Limited

People of Quantum Surgical

57 people are tracked at Quantum Surgical (16 in leadership, 41 in team).

NameRoleGroup
Fernand Badano
Co-FounderLeadership
Sophie Roca
Co-FounderLeadership
Lucien Blondel
Co-Founder & CTOLeadership
Bertin Nahum
Co-Founder & CEOLeadership
Yann Le Meur
Deputy R&d DirectorLeadership
Stephanie Moy
Head of CommunicationsLeadership
Yuriko M.
Director Of Customer ServicesLeadership
Bredon Jean-Michel
Director of Information Systems (CIO)Leadership
Kyle Rick
VP Of Global MarketingLeadership
Laetitia Messner
Chief Clinical OfficerLeadership
Herve Cointement
VP Sales EMEALeadership
Elise Lagacherie
Quality & Regulatory Affairs Director at Quantum Surgical SASLeadership
Marion Sabrou
HR DirectorLeadership
Andrew Zeringue
US Sales DirectorLeadership
Jonathan Limbert
US Vice President Of SalesLeadership
Thomas Klug
Vice President Of Customer SupportLeadership
Fanny Frauziols
Lead System EngineerTeam
Jérémy Bessac
Robotics EngineerTeam
Régis Merlino
Software ArchitectTeam
Xavier Carayol
DICOM Expert, Software ArchitectTeam

37 more people are available in the full profile.

Premium access

Complete people profiles for Quantum Surgical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Quantum Surgical

Figures of Quantum Surgicals Private Limited, the primary company behind Quantum Surgical, for FY 2025. Revenue was ₹11.14 Cr (-28% year on year). Net profit was ₹76.6 Lakh (7% margin). EBITDA was ₹1.04 Cr (9% margin). Revenue has grown at a compounded annual rate of -6% over three years and +2% over five years.

  • ₹11.14 CrRevenue · FY 2025 · -28% YoY
  • ₹76.6 LakhNet profit · 7% margin
  • ₹1.04 CrEBITDA · 9% margin
  • ₹1 LakhPaid-up capital
  • -6%Revenue CAGR, 3 years
  • +2%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Quantum Surgicals Private Limited are on its company page.

Premium access

Detailed financial statements for Quantum Surgical

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Quantum Surgical

Quantum Surgical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include NeuWave.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Microwave ablation systems for soft tissue and cancer are developed.
neuwave.comMadison, United States2004Feb 2026••••
Premium access

Complete acquisition details for Quantum Surgical

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Quantum Surgical

4 dated milestones of Quantum Surgical across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Quantum Surgical is founded.
  2. Funding First funding round of $50.0M.
  3. Funding Latest funding round, Debt – Conventional, of $32.5M.
  4. Acquisition Acquires NeuWave.

Web traffic of Quantum Surgical

The website of Quantum Surgical (quantumsurgical.com) receives about 5.2K visits a month.

  • Monthly visits
    5.2K

    ▼ 9.1% vs previous month

Similar websites

Websites whose visitors overlap most with Quantum Surgical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
chru-nancy.fr
100%
#959,029View details
hds-aphm.fr
hds-aphm.fr
94%
–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Quantum Surgical

Premium access

Complete news archive for Quantum Surgical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Quantum Surgical

Quantum Surgical was founded in 2010 and raised its 1st funding round 8 years after it was founded.

Quantum Surgical is headquartered in Montpellier, France. It is registered at Montpellier, Occitanie, France.

Bertin Nahum is the CEO of Quantum Surgical, as recorded in our data. They have also founded this company.

Quantum Surgical is a funded company, having raised a total of $98M across 5 funding rounds to date. The company's 1st funding round was a Series A of $50M, raised on Jun 2018.

The primary company behind Quantum Surgical, Quantum Surgicals Private Limited, reported revenue of ₹11.14 Cr for FY 2025, down 28% year on year.

Quantum Surgical was founded in 2010 in Montpellier, France, and operates in the medtech sector focused on surgical robotics. The Epione robotic platform is offered to support percutaneous ablation therapy, targeting liver cancer and inoperable tumors in the abdomen and lungs. Difficult-to-reach tumors are treated at early stages without open surgery, enabling precise interventions by physicians in oncology applications.

Quantum Surgical offers Epione Robotic Platform.

Quantum Surgical has made 1 acquisition, including NeuWave.

Quantum Surgical has 4 investors. Key investors include Caisse D Epargne, European Investment Bank, Bpifrance, and Ally Bridge Group.

Quantum Surgical operates through Quantum Surgicals Private Limited.

The legal entities of Quantum Surgical currently have 2 directors, including Sawan Rajendra Khokale, Sachin Rajendra Khokale.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available